Douglass Winthrop Advisors, LLC Novartis Ag Transaction History

Douglass Winthrop Advisors, LLC

$5.09 Billion
Q3 2024

A detailed history of Douglass Winthrop Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 7,008 shares of NVS stock, worth $689,236. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,008

Previous 7,008 -0.0%

Holding current value

$689,236

Previous $746,000 8.04%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$92.57 - $107.37 $12,959 - $15,031	-140 Reduced 1.96%	7,008 $746,000
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $20,006 - $22,778	210 Added 3.03%	7,148 $691,000
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $60,440 - $74,016	-800 Reduced 10.34%	6,938 $629,000
Q3 2022 Nov 15, 2022	BUY	$74.61 - $87.26 $577,332 - $675,217	7,738 New	7,738 $588,000
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $796,181 - $927,000	9,888 New	9,888 $836,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $381,922 - $422,318	-4,792 Reduced 33.49%	9,516 $832,000
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $28,623 - $33,299	-350 Reduced 2.39%	14,308 $1.17 Million
Q2 2021 Aug 02, 2021	SELL	$85.24 - $94.15 $42,620 - $47,075	-500 Reduced 3.3%	14,658 $1.34 Million
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $191,131 - $225,397	-2,289 Reduced 13.12%	15,158 $1.3 Million
Q4 2020 Jan 27, 2021	SELL	$78.07 - $94.43 $1.41 Million - $1.71 Million	-18,072 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $1.48 Million - $1.64 Million	18,072 New	18,072 $1.57 Million
Q2 2020 Jul 17, 2020	SELL	$80.93 - $91.1 $194,232 - $218,640	-2,400 Reduced 18.94%	10,270 $897,000
Q1 2020 Apr 23, 2020	BUY	$70.67 - $99.01 $34,486 - $48,316	488 Added 4.01%	12,670 $1.05 Million
Q4 2019 Jan 10, 2020	SELL	$84.35 - $95.37 $261,484 - $295,647	-3,100 Reduced 20.29%	12,182 $1.15 Million
Q3 2019 Oct 08, 2019	BUY	$85.54 - $94.26 $24,549 - $27,052	287 Added 1.91%	15,282 $1.33 Million
Q2 2019 Jul 10, 2019	SELL	$75.4 - $92.8 $416,585 - $512,720	-5,525 Reduced 26.92%	14,995 $1.37 Million
Q1 2019 Apr 09, 2019	SELL	$75.32 - $86.15 $88,500 - $101,226	-1,175 Reduced 5.42%	20,520 $1.97 Million
Q4 2018 Jan 16, 2019	SELL	$73.66 - $82.02 $51,562 - $57,414	-700 Reduced 3.13%	21,695 $1.86 Million
Q3 2018 Oct 12, 2018	SELL	$66.94 - $77.43 $753,075 - $871,087	-11,250 Reduced 33.44%	22,395 $1.93 Million
Q2 2018 Jul 24, 2018	SELL	$64.91 - $73.36 $27.7 Million - $31.3 Million	-426,996 Reduced 92.7%	33,645 $2.54 Million
Q1 2018 May 08, 2018	SELL	$70.39 - $84.15 $31.4 Million - $37.5 Million	-446,164 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $147,625 - $158,463	2,041 Added 0.46%	446,164 $37.5 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $32.9 Million - $34.3 Million	444,123	444,123 $0

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.

Account

Douglass Winthrop Advisors, LLC Novartis Ag Transaction History